CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
cryopreserved amniotic membranedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02766907
NCT02766907N/ACompleted
CompareCT.gov

Optimizing the Ocular Surface Prior to Cataract Surgery

BioTissue Holdings, Inc·interventional·Posted May 10, 2016·Updated Mar 19, 2019

In Brief

A clinical study evaluating cryopreserved amniotic membrane for Corneal Dystrophy, Epithelial Basement Membrane. Completed, enrolled 20 participants across 1 site.

Detailed Summary

Prospective study to evaluate the efficacy of using self-retained cryopreserved amniotic membrane after debridement in treating Epithelial Base Membrane Dystrophy (EBMD) to optimize the ocular surface integrity and intraocular lens calculation before cataract surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCorneal Dystrophy, Epithelial Basement Membrane
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMay 10, 2016
Enrollment StartMar 1, 2016
Primary CompletionJan 1, 2017
Study CompletionApr 1, 2018
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 10.1 years ago

Interventions

cryopreserved amniotic membranedevice

placement of cryopreserved amniotic membrane after routine debridement procedure for EBMD